Search Result "HDL subclasses"
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Cardioprotective Properties of HDL: Structural and Functional Considerations
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 18 Year: 2020 Page: 2964-2978
Author(s): Eleni Pappa,Moses S. Elisaf,Christina Kostara,Eleni Bairaktari,Vasilis K. Tsimihodimos
Subfractions and Subpopulations of HDL: An Update
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2881-2891
Author(s): M. Rizzo,J. Otvos,D. Nikolic,G. Montalto,P.P. Toth,M. Banach
Genetic Determinants of HDL Metabolism
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2855-2863
Author(s): A. Ossoli,M. Gomaraschi,G. Franceschini,L. Calabresi
Biological Consequences of Dysfunctional HDL
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1644-1664
Author(s): Angela Pirillo,Alberico Luigi Catapano,Giuseppe Danilo Norata
HDL Levels in Obesity
Ebook: Anti-Obesity Drug Discovery and Development
Volume: 1 Year: 2011
Author(s): Justina Costandi,Michelle Melone,Shirya Rashid
Doi: 10.2174/978160805163211101010021
High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1494-1503
Author(s): Laura Calabresi, Monica Gomaraschi, Guido Franceschini
Oxidative Stress, HDL and Atherosclerosis
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 7 Issue: 3 Year: 2008 Page: 158-165
Author(s): Jelena Vekic, Jelena Kotur-Stevuljevic, Aleksandra Zeljkovic, Aleksandra Stefanovic, Natasa Bogavac-Stanojevic, Ana Vujovic
High-density Lipoprotein (HDL) Dysfunction and the Future of HDL
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 5 Year: 2018 Page: 490-498
Author(s): Sibel Ertek
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos